Advertisement

Topics

Companies Related to "approves leukemia treatment developed Celgene Agios" [Most Relevant Company Matches] RSS

18:11 EST 20th November 2017 | BioPortfolio

Here are the most relevant search results for "approves leukemia treatment developed Celgene Agios" found in our extensive corporate database of over 50,000 company records.

Showing "approves leukemia treatment developed Celgene Agios" Companies 1–25 of 4,900+

Extremely Relevant

Agios Pharmaceuticals, Inc.

Agios is the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Agios has multiple first-in-class programs in cancer metabolism and inborn errors of metabolism advancing toward the clinic, in addition to an active research and discovery pipeline across ...


Celgene Corporation and Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals , Inc.

Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class investigational m...


Relevant

Agios Pharmaceuticals

Agios Pharmaceuticals is the first biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging field of cancer metabolism. To support and drive these efforts, Agios is building a robust platform integrating cancer biology, metabolomics, biochemistry and informatics to enable target and biomarker identification...

Celgene International Sàrl

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of in...

Celgene Cellular Therapeutics

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation.

Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the National Cancer Institute. Despite an acceptable safety database of over 2,000 treated patients, over 70 peer reviewed clinical publications that demonstrated efficacy in leukemi...

The Leukemia & Lymphoma Society (LLS)

The Leukemia & Lymphoma Society (® )(LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Washington Gas and Leukemia & Lymphoma Society (LLS)

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information a...

The Leukemia & Lymphoma Society and Reliant Energy

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and supp...

Preserve Our Legacy, Inc.

POL's mission is to educate individuals, especially minorities, about the benefits of stem cells and treatment options they provide for health disparities. In 2006, the founders of MMA, Brett and Shana Melius met then 2-year-old Jaden Hilton. At the time, Jaden was battling Leukemia, which inspired MMA to begin working with DKMS to find a donor for Jaden. Despite their efforts, Jaden lost his batt...

DKNY JEANS

St. Jude Children's Research Hospital® is the nation's leading pediatric research and treatment center devoted solely to children with cancer and other catastrophic diseases and the only pediatric cancer research center that covers all of the costs for treatment, travel, food, and lodging for a patient and a family member. Children come to St. Jude Children's Research Hospital® from across the c...

Celgene Corporation

Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and development team is working to extend the boundaries in the areas of small molecule immunotherapeutic and biocatalytic chiral chemistry by developing both new pharmaceuticals and chirally pure versions of ...

Celgene Corporation and BeiGene, Ltd.

SGX Pharmaceuticals

SGX Pharmaceuticals (formerly Structural GenomiX) is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.We are developing Troxatyl™, a novel compound that is currently in a pivotal Phase II/III clinical trial for the third-line treatment of Acute Myelogenous Leukemia (AML). We also plan to develop Troxatyl in combination with Ara...

The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society ® (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and supp...

Genoptix

Genoptix has developed a breadth of services that focus on the challenges of each phase of patient management to help in effective diagnosis, optimal treatment decisions and monitoring of hematopoietic diseases. We partner with community-based hematologist/oncologists to help them deliver the best possible personalized medicine.Genoptix COMPASS™ (Comprehensive Assessment) Services A hematopathol...

Eutropics Pharmaceuticals Inc.

Eutropics is addressing the need for improving the treatment of aggressive forms of leukemia, myeloma, lymphoma, and other cancers. The company is developing a novel diagnostic technology that will guide the use of established and experimental therapeutics, enabling the delivery of personalized medicines to patients suffering from cancer. www.eutropics.com

Traversa Therapeutics

Traversa Therapeutics, Inc. (www.traversathera.com) is a San Diego, California-based biopharmaceutical company engaged in the discovery, development and commercialization of RNAi technologies. The company strives to rapidly advance siRNA platform delivery technologies for use in its internal oncology programs and by sanofi-aventis in targeting a wide varie...

EUSA Pharma Inc

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...

EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...

Eagles Fly for Leukemia

Leukemia & Lymphoma Society

Munich Leukemia Laboratory

Aegera Therapeutics Inc

Aegera Therapeutics Inc. (“Aegera”) is a clinical stage biotechnology company focused on developing drugs that control apoptosis to address major unmet medical needs. Our two lead clinical programs are in development to induce apoptosis to kill cancer cells and to prevent apoptosis to save injured neuronal cells. AEG35156 targets the anti-apoptotic protein XIAP, and is currently in multiple hu...


More From BioPortfolio on "approves leukemia treatment developed Celgene Agios"

Quick Search
Advertisement
 

Corporate Database Quicklinks